MedImmune Inc

Activities: Manufacturing Research & Development Pharmaceutical

Trending Articles

  1. Lonza upgrades clinical manufacturing services at Bend (US) site The new equipment will support bottling of solid dosage forms, including tablets and powder-filled capsules
  2. ICROM has acquired HOLODIAG ICROM srl, an italian API CDMO, has acquired the French-based Contract Research Organization HOLODIAG sas specialized in solid state studies and crystallization services of...
  3. Cellular Origins and 3P innovation collaborate to automate the CGT manufacturing process The companies will integrate their technologies to automate the sterile filling of vials and other open format containers in commercial CGT manufacturing
  4. At CPHI Milan, TekniPlex Healthcare to Highlight New Solutions for Single-use Bioprocessing, Cell & Gene Therapies Company also will provide live demos of next-generation automatic filler-sealer for single-dose plastic vials, and showcase sustainability-minded blister packaging, as well as...
  5. Meet Gaelic Laboratories at CPHI Milan Visit us in Hall 5 to learn more about our advanced Beta-Lactam manufacturing facilities, and our newly-equipped laboratories offering rapid and cost-effective release testing

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Media

Merck is set to lead pharmaceutical licensing deals in 2018

GlobalData, a specialist data and analytics company, expects that 2018 is likely to be Merck’s year in terms of research and development collaboration
Research & Development

MedImmune and Abpro enter into a collaborative agreement for a novel bispecific antibody

Agreement to result in new spin out company, AbMed, as subsidiary of Abpro
Research & Development

AstraZeneca launches integrated genomics approach to transform drug discovery and development

The initiative includes new collaborations with Human Longevity, the Wellcome Trust Sanger Institute and The Institute for Molecular Medicine
Research & Development

AstraZeneca and Moderna Therapeutics link up to develop immuno-oncology mRNA therapeutics

Extension to an mRNA agreement for cardiovascular, metabolic and renal diseases set up in 2013
Manufacturing

Wacker Biotech grants MedImmune licence to use Esetec technology to manufacture antibody fragment

To help improve productivity and simplify the purification process
Research & Development

AstraZeneca signs third cancer deal in seven days

MedImmune enters into cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals
Research & Development

Medimmune partners with the University of Sheffield to innovate cell factory technology

Partnership will create tools that could increase the yield and predictability of engineered proteins such as bispecific antibodies to treat a range of diseases
Subscribe now